1. Home
  2. NTRA vs HUBB Comparison

NTRA vs HUBB Comparison

Compare NTRA & HUBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$277.90

Market Cap

29.1B

Sector

Health Care

ML Signal

HOLD

Logo Hubbell Inc

HUBB

Hubbell Inc

HOLD

Current Price

$484.11

Market Cap

25.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
HUBB
Founded
2003
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
29.1B
25.4B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
NTRA
HUBB
Price
$277.90
$484.11
Analyst Decision
Strong Buy
Buy
Analyst Count
15
8
Target Price
$259.07
$517.88
AVG Volume (30 Days)
1.5M
658.0K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
1.04%
EPS Growth
0.65
15.10
EPS
N/A
3.41
Revenue
$210,939,000.00
$5,844,600,000.00
Revenue This Year
$18.08
$10.41
Revenue Next Year
$19.65
$5.49
P/E Ratio
N/A
$142.75
Revenue Growth
N/A
3.84
52 Week Low
$131.81
$403.82
52 Week High
$279.42
$565.50

Technical Indicators

Market Signals
Indicator
NTRA
HUBB
Relative Strength Index (RSI) 78.21 45.37
Support Level $186.96 $460.52
Resistance Level N/A $507.71
Average True Range (ATR) 13.08 16.49
MACD 4.73 -1.41
Stochastic Oscillator 99.56 23.34

Price Performance

Historical Comparison
NTRA
HUBB

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.

Share on Social Networks: